Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 20 | Next »

1

Journal article

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Liu, C, Ginn, HM, Dejnirattisai, W, et al.
2021-06-16

2

Journal article

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Clemens, SAC, Folegatti, PM, Emary, KRW, et al.
2021-10-06

3

Journal article

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge

McMahon, M, Asthagiri Arunkumar, G, Liu, W-C, et al.
2019-08-21

4

Journal article

Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults

Coughlan, L, Sridhar, S, Payne, R, et al.
2018-02-15

5

Journal article

Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule

Rollier, CS, Spencer, AJ, Sogaard, KC, et al.
2020-03-31

6

Journal article

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Feng, S, Phillips, DJ, White, T, et al.
2021-09-29

7

Journal article

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Voysey, M, Costa Clemens, SA, Madhi, SA, et al.
2021-02-19

8

Journal article

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Spencer, AJ, McKay, PF, Belij-Rammerstorfer, S, et al.
2021-05-17

9

Journal article

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

Lambe, T, Spencer, AJ, Thomas, KM, et al.
2021-07-26

10

Journal article

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Flaxman, A, Marchevsky, NG, Jenkin, D, et al.
2021-09-01

TO TOP